Literature DB >> 8111526

Evaluation of the benefits of gastric tube feeding in an elderly population.

J P Weaver1, P Odell, C Nelson.   

Abstract

OBJECTIVE: To assess the benefits of gastric tube feeding in an elderly community hospital population.
SUBJECTS: One hundred consecutive patients who required feeding gastrostomies from July 1984 through June 1987.
SETTING: Durham (NC) Regional Hospital, a 380-bed community hospital.
METHODS: Patients were evaluated using a quality of life scale (QL scale) adapted from Spitzer's QL Index. The evaluation was based on hospital records at the time of tube placement and interviews with patients or family members at follow-up between June 1991 and March 1992. Subjective evaluation of the benefits of gastric tube feeding were obtained in interviews with patients or their families at follow-up.
RESULTS: Overall there was no significant change in the objective evaluation of quality of life at follow-up. Men, patients over 76 years of age, and patients with chronic illnesses such as multiple strokes or dementia showed the poorest response on the QL scale. Subjective evaluation by patients or their family members was positively correlated with objective evaluation on the QL scale. Family members of patients who showed the poorest response on the QL scale were more likely than other family members to respond no to the question, "Would you want this done to you if you were in his/her situation?"
CONCLUSIONS: Our QL scale provides a good indication of patients' and family members' subjective evaluation of the benefits of gastrostomy tube feeding after 4 to 8 years. Thus, the scale should be helpful to physicians who must consult with patients and their families and make decisions about the use of this procedure. The significant discrepancy between family members' evaluations of the benefit of the procedure to the patient and their refusal of the procedure for themselves if they were in the patient's situation confirms the need for advance directives and the importance of conscientious implementation of the Patient Self Determination Act of 1990.

Entities:  

Keywords:  Death and Euthanasia; Durham Regional Hospital (NC); Empirical Approach; Professional Patient Relationship

Mesh:

Year:  1993        PMID: 8111526     DOI: 10.1001/archfami.2.9.953

Source DB:  PubMed          Journal:  Arch Fam Med        ISSN: 1063-3987


  6 in total

1.  The development and validation of a quality-of-life questionnaire for head and neck cancer patients with enteral feeding tubes: the QOL-EF.

Authors:  Christiaan Seimeon Michael Stevens; Betty Lemon; Gina A Lockwood; John N Waldron; Andrea Bezjak; Jolie Ringash
Journal:  Support Care Cancer       Date:  2010-06-24       Impact factor: 3.603

2.  Decision-making for long-term tube-feeding in cognitively impaired elderly people.

Authors:  S L Mitchell; F M Lawson
Journal:  CMAJ       Date:  1999-06-15       Impact factor: 8.262

3.  Nutritional status and quality of life in patients with percutaneous endoscopic gastrostomy (PEG) in practice: prospective one-year follow-up.

Authors:  Joachim Klose; Walter Heldwein; Michael Rafferzeder; Frederike Sernetz; Manfred Gross; Klaus Loeschke
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

4.  Indications for percutaneous endoscopic gastrostomy and survival in old adults.

Authors:  Anna Malmgren; Gunnel Wärn Hede; Brita Karlström; Tommy Cederholm; Per Lundquist; Mikael Wirén; Gerd Faxén-Irving
Journal:  Food Nutr Res       Date:  2011-07-20       Impact factor: 3.894

Review 5.  Enteral tube feeding for people with severe dementia.

Authors:  Nathan Davies; Yolanda Barrado-Martín; Victoria Vickerstaff; Greta Rait; Akiko Fukui; Bridget Candy; Christina H Smith; Jill Manthorpe; Kirsten J Moore; Elizabeth L Sampson
Journal:  Cochrane Database Syst Rev       Date:  2021-08-13

6.  Acute Shunt Malfunction Caused by Percutaneous Endoscopic Gastrostomy without Shunt Infection.

Authors:  Jingyu Choi; Seung Seog Ki; Seoungwoo Park
Journal:  J Korean Neurosurg Soc       Date:  2014-10-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.